William Blakely

William Blakely is a notable inventor based in County Down, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for treating various conditions. With a total of six patents to his name, Blakely's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents is a stable aqueous suspension that comprises a non-steroidal anti-inflammatory drug, an aqueous buffer system, xanthan gum, polyvinyl pyrrolidone, and glycerol. This suspension is notable for being free from pregelatinized starch, amino polycarboxylic acid, microcrystalline cellulose, hydroxypropylmethyl cellulose, polyoxyethylene sorbitan monooleate, silicon dioxide, and taste-modifying agents. Another significant patent is a long-acting parasiticidal composition that contains a salicylanilide compound, a polymeric species, and at least one other anti-parasitic compound. This composition is designed for treating animals suffering from parasites and includes ivermectin and a salicylanilide such as closantel, which improves the bioavailability of the treatment.

Career Highlights

William Blakely is currently associated with Norbrook Laboratories Limited, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing treatments that are both effective and safe for use in veterinary medicine.

Collaborations

Blakely has collaborated with notable coworkers such as Lillian Cromie and Sean Duffy, contributing to a dynamic team focused on pharmaceutical advancements.

Conclusion

William Blakely's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the industry and improve treatment options for various conditions.

This text is generated by artificial intelligence and may not be accurate.